InsiderTrades

Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.

Accepted 2023-03-10 00:00:00 ET · period of report 2023-03-09 · accession 0001209191-23-018041 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-10 2023-03-09 TMCI Elder Scot Michael *See "Remarks" S - Sale $24.41 -177 22.4K -0.8% -$4,321
D 2023-03-10 2023-03-10 TMCI Elder Scot Michael *See "Remarks" A - Grant $0.00 +27.5K 49.9K +123% $0
D 2023-03-10 2023-03-10 TMCI Elder Scot Michael *See "Remarks" A - Grant $0.00 +62.3K 62.3K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-09 S D 177 $24.41 22,421 D — — (F2) Includes 18,143 RSUs.
2 Common Common Stock 2023-03-10 A A 27,500 $0.00 49,921 D — — (F3) Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date. (F4) Includes 45,643 RSUs.
3 Derivative Stock Option (Right to Buy) 2023-03-10 A A 62,300 $0.00 62,300 D $24.07 · — to 2033-03-10 62,300 Stock Option (Right to Buy) (F5) The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.